Menveo®: a novel quadrivalent meningococcal CRM197conjugate vaccine against serogroups A, C, W-135 and Y
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Menveo®: a novel quadrivalent meningococcal CRM197conjugate vaccine against serogroups A, C, W-135 and Y
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 10, Issue 1, Pages 21-33
Publisher
Informa UK Limited
Online
2010-12-16
DOI
10.1586/erv.10.147
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents
- (2011) Christopher J. Gill et al. Human vaccines & immunotherapeutics
- Epidemiological Profile of Meningococcal Disease in the United States
- (2010) Lee H. Harrison CLINICAL INFECTIOUS DISEASES
- Prevention of Meningococcal Disease: Current Use of Polysaccharide and Conjugate Vaccines
- (2010) Gregory A. Poland CLINICAL INFECTIOUS DISEASES
- Epidemiology and Meningococcal Serogroup Distribution in the United States
- (2010) Jody H. Hershey et al. CLINICAL PEDIATRICS
- Genetic Study of Capsular Switching between Neisseria meningitidis Sequence Type 7 Serogroup A and C Strains
- (2010) Q. Wang et al. INFECTION AND IMMUNITY
- Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America
- (2010) D. Stamboulian et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Population Structure and Capsular Switching of InvasiveNeisseria meningitidisIsolates in the Pre–Meningococcal Conjugate Vaccine Era—United States, 2000–2005
- (2010) Lee H. Harrison et al. JOURNAL OF INFECTIOUS DISEASES
- Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis
- (2010) Karen Edmond et al. LANCET INFECTIOUS DISEASES
- Meningococcal group A, C, Y and W-135 conjugate vaccine
- (2010) Lee H. Harrison et al. NATURE REVIEWS DRUG DISCOVERY
- Advances in the Development of Vaccines againstNeisseria meningitidis
- (2010) Lionel K.K. Tan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Isolation and characterization of Neisseria meningitidis in the vaccine era. Who needs what and when?
- (2010) Per Olcén et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines
- (2010) A. Arguedas et al. VACCINE
- 2010 FIFA World Cup South Africa: Travel health issues and new options for protection against meningococcal disease
- (2010) Jane N. Zuckerman et al. Travel Medicine and Infectious Disease
- Sequelae due to bacterial meningitis among African children: a systematic literature review
- (2009) Meenakshi Ramakrishnan et al. BMC Medicine
- Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective Activity
- (2009) J. S. Plested et al. Clinical and Vaccine Immunology
- Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
- (2009) K. S. Reisinger et al. Clinical and Vaccine Immunology
- Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents
- (2009) Lisa A. Jackson et al. CLINICAL INFECTIOUS DISEASES
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal Disease
- (2009) Amanda C. Cohn et al. CLINICAL INFECTIOUS DISEASES
- Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers
- (2009) S. A. Halperin et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy
- (2009) David Pace Expert Review of Vaccines
- Meningococcal vaccines: a neglected topic in travel medicine?
- (2009) Annelies Wilder-Smith Expert Review of Vaccines
- Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
- (2009) Caroline L Trotter et al. Expert Review of Vaccines
- Evidence for Capsule Switching between Carried and Disease-Causing Neisseria meningitidis Strains
- (2009) A. J. Beddek et al. INFECTION AND IMMUNITY
- Vaccinology in the genome era
- (2009) C. Daniela Rinaudo et al. JOURNAL OF CLINICAL INVESTIGATION
- W135 Invasive Meningococcal Strains Spreading in South America: Significant Increase in Incidence Rate in Argentina
- (2009) A. M. Efron et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Emergence of Ciprofloxacin-ResistantNeisseria meningitidisin North America
- (2009) Henry M. Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- MODERN TRENDS IN MORTALITY FROM MENINGOCOCCAL DISEASE IN AUSTRALIA
- (2009) Daniel Simpkins et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada
- (2009) Julie A. Bettinger et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A Randomized Trial to Determine the Tolerability and Immunogenicity of a Quadrivalent Meningococcal Glycoconjugate Vaccine in Healthy Adolescents
- (2009) Lisa A. Jackson et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages
- (2009) Michael Bröker et al. VACCINE
- Quadrivalent meningococcal conjugate vaccines
- (2009) David Pace et al. VACCINE
- Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease
- (2009) Carl E. Frasch et al. VACCINE
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
- Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age
- (2009) S. Black et al. VACCINE
- Meningococcal disease and prevention at the Hajj
- (2009) Ray Borrow Travel Medicine and Infectious Disease
- Prevalence and antimicrobial resistance pattern of bacterial meningitis in Egypt
- (2009) Lamyaa Shaban et al. Annals of Clinical Microbiology and Antimicrobials
- Emergence of Endemic Serogroup W135 Meningococcal Disease Associated with a High Mortality Rate in South Africa
- (2008) A. von Gottberg et al. CLINICAL INFECTIOUS DISEASES
- Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002–2006
- (2008) M. J. SIMÕES et al. EPIDEMIOLOGY AND INFECTION
- Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera
- (2008) D. M. Granoff et al. INFECTION AND IMMUNITY
- Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants
- (2008) Matthew D. Snape et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
- (2008) Martin C. J. Maiden et al. JOURNAL OF INFECTIOUS DISEASES
- Influenza and meningococcal disease: Lessons for travellers and government from 2 epidemic diseases
- (2008) Robert Booy et al. Travel Medicine and Infectious Disease
- Meningococcal disease: Risk for international travellers and vaccine strategies
- (2007) Annelies Wilder-Smith Travel Medicine and Infectious Disease
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started